Low dose treatment effectively improves BMD in Chinese women on alendronate

Details

Created on 12-27-2012

Researchers in China studied 639 postmenopausal women with low bone mass and osteoporosis and found, after 12 months, that treatment with the bisphosphonate alendronate every two weeks was as effective in increasing spine and hip bone mineral density as the standard weekly treatment. They conclude that a lower dose may be a safe and cost effective way to treat osteoporosis.

Read the abstract.